Literature DB >> 11490021

Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium.

S K Shaw1, P S Bamba, B N Perkins, F W Luscinskas.   

Abstract

Vascular endothelial-cadherin (VE-cadherin) is a component of the adherens junctions of endothelial cells whose role in endothelial transmigration of leukocytes has been controversial. Using a VE-cadherin/green fluorescent protein fusion construct (VEcadGFP) that mimics the native molecule, we visualized alterations in endothelial junctional structure in real time during transmigration of human neutrophils and monocytes in an in vitro flow model. We observed abundant transmigration occurring exclusively at the cell borders (paracellularly). Surprisingly, transmigration occurred both through de novo formation of transient gaps in VEcadGFP junctional distribution, and also through preexisting gaps. De novo gaps 4-6 microm in size were formed after a leukocyte arrived at a junction, whereas preexisting gaps were present even before the leukocyte had interacted with the endothelial cells contributing to a junction. Gaps rapidly resealed within 5 min after leukocyte transmigration. Migrating leukocytes appeared to push aside VEcadGFP in the plane of the junction, and this displaced material subsequently diffused back to refill the junction. To our knowledge, this is the first example where molecular events at the lateral junction have been tracked in real time during transmigration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11490021     DOI: 10.4049/jimmunol.167.4.2323

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  109 in total

Review 1.  Breaking into the epithelial apical-junctional complex--news from pathogen hackers.

Authors:  Roger Vogelmann; Manuel R Amieva; Stanley Falkow; W James Nelson
Journal:  Curr Opin Cell Biol       Date:  2004-02       Impact factor: 8.382

Review 2.  Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled?

Authors:  Pingnian He
Journal:  Cardiovasc Res       Date:  2010-05-13       Impact factor: 10.787

Review 3.  Mechanisms of leukocyte transendothelial migration.

Authors:  William A Muller
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

4.  p120-Catenin prevents neutrophil transmigration independently of RhoA inhibition by impairing Src dependent VE-cadherin phosphorylation.

Authors:  Pilar Alcaide; Roberta Martinelli; Gail Newton; Marcie R Williams; Alejandro Adam; Peter A Vincent; Francis W Luscinskas
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-30       Impact factor: 4.249

Review 5.  How leukocytes cross the vascular endothelium.

Authors:  Dietmar Vestweber
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

6.  Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.

Authors:  Kunihiko Hatanaka; Michael Simons; Masahiro Murakami
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

Review 7.  Rho GTPases and leucocyte-induced endothelial remodelling.

Authors:  Jaime Millán; Anne J Ridley
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

Review 8.  Active participation of endothelial cells in inflammation.

Authors:  Joan M Cook-Mills; Tracy L Deem
Journal:  J Leukoc Biol       Date:  2005-01-03       Impact factor: 4.962

9.  Polarized localization of epithelial CXCL11 in chronic obstructive pulmonary disease and mechanisms of T cell egression.

Authors:  Joanna C Porter; Mary Falzon; Alan Hall
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

10.  Complement activation on neutrophils initiates endothelial adhesion and extravasation.

Authors:  Antonina Akk; Luke E Springer; Lihua Yang; Samantha Hamilton-Burdess; John D Lambris; Huimin Yan; Ying Hu; Xiaobo Wu; Dennis E Hourcade; Mark J Miller; Christine T N Pham
Journal:  Mol Immunol       Date:  2019-09-19       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.